Bortezomib: putting mantle cell lymphoma on death row.
Wei
Andrew H
AH
Department of Malignant Haematology and Stem Cell Transplantion, The Alfred Hospital, Melbourne, Victoria, Australia. a.wei@alfred.org.au
Roberts
Andrew W
AW
D051017:Apoptosis Regulatory Proteins; D051023:BH3 Interacting Domain Death Agonist Protein; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000209:etiology; D011480:Protease Inhibitors; D011719:Pyrazines / Q000627:therapeutic use*
D051017:Apoptosis Regulatory Proteins; D051023:BH3 Interacting Domain Death Agonist Protein; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib